Efficacy of Homoeopathic prophylaxis Arsenicum Album against COVID-19
- Registration Number
- CTRI/2020/12/029745
- Lead Sponsor
- School of Public Health SRMIST
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15249
Participants who are capable of giving signed informed consent.
6 months and older individuals in the study area,
The participant is in good health in the opinion of the investigator as determined by a medical and psychiatric history.
The participant must be willing and able to comply with study restrictions, to remain
at the study area for the required duration during the study period and be available for
the follow-up evaluations, as specified in this protocol.
COVID-19 positive as determined by RT-PCR, or other approved commercial or public health assay. Children less than 6 months
Severe chronic kidney disease or cardiovascular diseases, cancer, AIDS or other life-threatening diseases.
Immunocompromised patients taking (presently or anytime during last 90 days) immunosuppressant medication
The person has participated in a clinical study of a new chemical entity or a prescription medicine within 3 months before administration of the first dose of the IMP
The patient cannot participate or successfully complete the study, in the opinion of their healthcare provider or the investigator for any of the following reasons
mentally or legally incapacitated or unable to give consent for any reason o unable to be contacted in case of emergency
The patient is an employee of the sponsorparticipating study center who is directly involved in the study or is the relative of such an employee
The patient has a history of alcohol and/or drug abuse that in the investigatorâ??s opinion could interfere with the study evaluations or the patientâ??s safety has any other condition, which, in the opinion of the investigator makes the patient inappropriate for inclusion in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method